Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505544 · ClinicalTrials.gov registry record
Measuring Sleep Disturbance Among Cancer Patients
A clinical trial of Advanced Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 459
- Enrollment target
- 2
- Study locations
NCT00505544: Completed study of Advanced Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00505544 is a study of Advanced Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 459 participants, above the 243-participant average among 122 other Advanced Cancer trials with a reported enrollment target (89% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505544, a study of Advanced Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 459 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objectives: Primary Objectives: 1. To establish concurrent criterion-related validity of the Brief Sleep Disturbance Scale (BSDS) by correlating the scale with the Pittsburgh Sleep Quality Index. 2. To evaluate the construct validity of the BSDS through exploratory factor analysis. 3. To examine possible predictors of sleep disturbance. 4. To evaluate the reliability of the BSDS using Cronbach's coefficient alpha and test-retest reliability. 5. To evaluate the sensitivity of the BSDS by administering it to the same group of patients (n = 60) prior to treatment with a regimen associated with sleep disturbance, during 4 weeks of treatment, and upon completion of treatment. 6. To evaluate the psychometric properties of the BSDS in a sample of community dwelling adults. Secondary Objective: 1\. To obtain pilot data from a small sample of patients who will wear an actigraph for one week.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- DEVICE Actigraph
Study Locations (2)
Texas
- Lyndon Baines Johnson General Hospital - Houston
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 459 participants |
| Start Date | 2005-08 |
| Est. Completion | 2022-07-11 |
What the finished NCT00505544 record still lists
NCT00505544 is an observational study that tracks outcomes without assigning an intervention. The registered 459 participants enrollment target is mid-sized for trials with a published cap, above the 243-participant average among 122 other Advanced Cancer trials with a reported enrollment target (89% higher).
The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.
NCT00505544 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00505544 about?
NCT00505544 is a clinical study titled "Measuring Sleep Disturbance Among Cancer Patients". Objectives: Primary Objectives: 1. To establish concurrent criterion-related validity of the Brief Sleep Disturbance Scale (BSDS) by correlating the scale with the Pittsburgh Sleep Quality Index. 2. To evaluate the construct validity of the BSDS through exploratory factor analysis. 3. To examine p...
What is the current status of trial NCT00505544?
This trial is currently completed. The enrollment target is 459 participants. The study started on 2005-08. Estimated completion is 2022-07-11.
What conditions does trial NCT00505544 study?
This clinical trial studies the following conditions: Advanced Cancer.
What interventions are being tested in trial NCT00505544?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Actigraph (DEVICE).
Who is sponsoring clinical trial NCT00505544?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00505544 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00505544's enrollment target sits among peer trials
459 9th of 122 higher than 114 of 122 other Advanced Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Disparities in Precision Oncology
RECRUITING
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
RECRUITING · Phase 2
-
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
RECRUITING · NA
-
Phase 1b Trial of BMS-986504 in Combination With Olaparib in Patients With MTAP Loss
RECRUITING · Phase 1
-
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia